Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Dermatol ; 177(3): 621-622, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28940266

Assuntos
Verrugas , Humanos
2.
Clin Exp Dermatol ; 42(6): 645-647, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28691211

RESUMO

The MS1/SVR system, in which MS1 represents immortalized endothelial cells and SVR represents MS1 cells transformed with oncogenic human-rat sarcoma protein (H-Ras), has been used for around 20 years as a valuable tool to study angiogenesis and carcinogenesis. Despite the use of these cells in numerous studies, a comprehensive profile of the signalling differences due to oncogenic H-Ras transformation has not been performed previously. In this study, we profiled the well-known MS1 and SVR cell lines using a combination of both Western blot and gene chip assays.


Assuntos
Genes ras/fisiologia , Hemangiossarcoma/metabolismo , Transdução de Sinais , Animais , Western Blotting , Linhagem Celular Tumoral , Hemangiossarcoma/genética , Camundongos , Neovascularização Patológica , Análise de Sequência com Séries de Oligonucleotídeos , Coelhos
3.
Oncogene ; 36(41): 5709-5721, 2017 10 12.
Artigo em Inglês | MEDLINE | ID: mdl-28581518

RESUMO

Tumor suppressor and upstream master kinase Liver kinase B1 (LKB1) plays a significant role in suppressing cancer growth and metastatic progression. We show that low-LKB1 expression significantly correlates with poor survival outcome in breast cancer. In line with this observation, loss-of-LKB1 rendered breast cancer cells highly migratory and invasive, attaining cancer stem cell-like phenotype. Accordingly, LKB1-null breast cancer cells exhibited an increased ability to form mammospheres and elevated expression of pluripotency-factors (Oct4, Nanog and Sox2), properties also observed in spontaneous tumors in Lkb1-/- mice. Conversely, LKB1-overexpression in LKB1-null cells abrogated invasion, migration and mammosphere-formation. Honokiol (HNK), a bioactive molecule from Magnolia grandiflora increased LKB1 expression, inhibited individual cell-motility and abrogated the stem-like phenotype of breast cancer cells by reducing the formation of mammosphere, expression of pluripotency-factors and aldehyde dehydrogenase activity. LKB1, and its substrate, AMP-dependent protein kinase (AMPK) are important for HNK-mediated inhibition of pluripotency factors since LKB1-silencing and AMPK-inhibition abrogated, while LKB1-overexpression and AMPK-activation potentiated HNK's effects. Mechanistic studies showed that HNK inhibited Stat3-phosphorylation/activation in an LKB1-dependent manner, preventing its recruitment to canonical binding-sites in the promoters of Nanog, Oct4 and Sox2. Thus, inhibition of the coactivation-function of Stat3 resulted in suppression of expression of pluripotency factors. Further, we showed that HNK inhibited breast tumorigenesis in mice in an LKB1-dependent manner. Molecular analyses of HNK-treated xenografts corroborated our in vitro mechanistic findings. Collectively, these results present the first in vitro and in vivo evidence to support crosstalk between LKB1, Stat3 and pluripotency factors in breast cancer and effective anticancer modulation of this axis with HNK treatment.


Assuntos
Compostos de Bifenilo/administração & dosagem , Neoplasias da Mama/tratamento farmacológico , Lignanas/administração & dosagem , Proteínas Serina-Treonina Quinases/genética , Fator de Transcrição STAT3/genética , Quinases Proteína-Quinases Ativadas por AMP , Animais , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Movimento Celular/genética , Transformação Celular Neoplásica , Feminino , Humanos , Camundongos , Células-Tronco Neoplásicas/efeitos dos fármacos , Células-Tronco Neoplásicas/patologia , Proteínas Serina-Treonina Quinases/biossíntese , Fator de Transcrição STAT3/antagonistas & inibidores , Ensaios Antitumorais Modelo de Xenoenxerto
4.
Oncogene ; 35(18): 2287-98, 2016 05 05.
Artigo em Inglês | MEDLINE | ID: mdl-26257063

RESUMO

The unique characteristic of head and neck squamous cell carcinoma (HNSCC) is that local invasion rather than distant metastasis is the major route for dissemination. Therefore, targeting the locally invasive cancer cells is more important than preventing systemic metastasis in HNSCC and other invasive-predominant cancers. We previously demonstrate a specific mechanism for HNSCC local invasion: the epithelial-mesenchymal transition (EMT) regulator Twist1 represses microRNA let-7i expression, leading to the activation of the small GTPase Rac1 and engendering the mesenchymal-mode movement in three-dimensional (3D) culture. However, targeting the EMT regulator is relatively difficult because of its transcription factor nature and the strategy for confining HNSCC invasion to facilitate local treatment is limited. Imipramine blue (IB) is a newly identified anti-invasive compound that effectively inhibits glioma invasion. Here we demonstrate that in HNSCC cells, a noncytotoxic dose of IB represses mesenchymal-mode migration in two-and-a-half-dimensional/3D culture system. IB suppresses EMT and stemness of HNSCC cells through inhibition of Twist1-mediated let-7i downregulation and Rac1 activation and the EMT signalling. Mechanistically, IB inhibits reactive oxygen species-induced nuclear factor-κB pathway activation. Importantly, IB promotes degradation of the EMT inducer Twist1 by enhancing F-box and leucine-rich repeat protein 14 (FBXL14)-mediated polyubiquitination of Twist1. Together, this study demonstrates the potent anti-invasion and EMT-inhibition effect of IB, suggesting the potential of IB in treating local invasion-predominant cancers.


Assuntos
Antineoplásicos/farmacologia , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Proteínas F-Box/metabolismo , Neoplasias de Cabeça e Pescoço/metabolismo , Neoplasias de Cabeça e Pescoço/patologia , Imipramina/farmacologia , Proteólise/efeitos dos fármacos , Proteína 1 Relacionada a Twist/metabolismo , Ubiquitina-Proteína Ligases/metabolismo , Animais , Linhagem Celular Tumoral , Transição Epitelial-Mesenquimal/efeitos dos fármacos , Humanos , Camundongos , NF-kappa B/metabolismo , Invasividade Neoplásica , Carcinoma de Células Escamosas de Cabeça e Pescoço , Ubiquitinação/efeitos dos fármacos
6.
Curr Mol Med ; 14(6): 783-92, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25056540

RESUMO

Skeletal mass is regulated by the coordinated action of bone forming osteoblasts and bone resorbing osteoclasts. Accelerated rates of bone resorption relative to bone formation lead to net bone loss and the development of osteoporosis, a devastating disease that predisposes the skeleton to fractures. Bone fractures are associated with significant morbidity and in the case of hip fractures, high mortality. Gentian violet (GV), a cationic triphenylmethane dye, has long been used as an antifungal and antibacterial agent and is presently under investigation as a potential chemotherapeutic and antiangiogenic agent. However, effects on bone cells have not been previously reported and the mechanisms of action of GV, are poorly understood. In this study we show that GV suppresses receptor activator of NF-κB ligand (RANKL)-induced differentiation of RAW264.7 osteoclast precursors into mature osteoclasts, but paradoxically stimulates the differentiation of MC3T3 cells into mineralizing osteoblasts. These actions stem from the capacity of GV to suppress activation of the nuclear factor kappa B (NF-κB) signal transduction pathway that is required for osteoclastogenesis, but inhibitory to osteoblast differentiation and activity. Our data reveal that GV is an inhibitor of NF-κB activation and may hold promise for modulation of bone turnover to promote a balance between bone formation and bone resorption, favorable to gain of bone mass.


Assuntos
Violeta Genciana/farmacologia , NF-kappa B/antagonistas & inibidores , Osteoblastos/efeitos dos fármacos , Osteoclastos/efeitos dos fármacos , Osteoclastos/metabolismo , Animais , Apoptose/efeitos dos fármacos , Proteína Morfogenética Óssea 2/metabolismo , Calcificação Fisiológica/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular , Linfotoxina-alfa/farmacologia , Camundongos , NF-kappa B/genética , Osteoblastos/metabolismo , Osteogênese/efeitos dos fármacos , Ligante RANK/metabolismo , Proteínas Smad/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Fator de Necrose Tumoral alfa/farmacologia
7.
Br J Cancer ; 109(2): 433-43, 2013 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-23807168

RESUMO

BACKGROUND: Glucose regulated protein 78 (GRP78) functions as a sensor of endoplasmic reticulum (ER) stress. The aim of this study was to test the hypothesis that molecules that bind to GRP78 induce the unfolded protein response (UPR) and enhance cell death in combination with ER stress inducers. METHODS: Differential scanning calorimetry (DSC), measurement of cell death by flow cytometry and the induction of ER stress markers using western blotting. RESULTS: Epigallocatechin gallate (EGCG), a flavonoid component of Green Tea Camellia sinensis, and honokiol (HNK), a Magnolia grandiflora derivative, bind to unfolded conformations of the GRP78 ATPase domain. Epigallocatechin gallate and HNK induced death in six neuroectodermal tumour cell lines tested. Levels of death to HNK were twice that for EGCG; half-maximal effective doses were similar but EGCG sensitivity varied more widely between cell types. Honokiol induced ER stress and UPR as predicted from its ability to interact with GRP78, but EGCG was less effective. With respect to cell death, HNK had synergistic effects on melanoma and glioblastoma cells with the ER stress inducers fenretinide or bortezomib, but only additive (fenretinide) or inhibitory (bortezomib) effects on neuroblastoma cells. CONCLUSION: Honokiol induces apoptosis due to ER stress from an interaction with GRP78. The data are consistent with DSC results that suggest that HNK binds to GRP78 more effectively than EGCG. Therefore, HNK may warrant development as an antitumour drug.


Assuntos
Antineoplásicos Fitogênicos/uso terapêutico , Apoptose/efeitos dos fármacos , Compostos de Bifenilo/uso terapêutico , Catequina/análogos & derivados , Proteínas de Choque Térmico/metabolismo , Lignanas/uso terapêutico , Neoplasias/tratamento farmacológico , Antineoplásicos Fitogênicos/metabolismo , Compostos de Bifenilo/metabolismo , Catequina/metabolismo , Catequina/uso terapêutico , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Chaperona BiP do Retículo Endoplasmático , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Proteínas de Choque Térmico/antagonistas & inibidores , Humanos , Lignanas/metabolismo , Terapia de Alvo Molecular , Peso Molecular , Neoplasias/patologia , Ligação Proteica/efeitos dos fármacos
8.
Br J Dermatol ; 166(1): 124-8, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21790523

RESUMO

BACKGROUND: Pachyonychia congenita (PC) is a rare keratin disorder that typically presents with nail dystrophy and focal plantar keratoderma. We present seven cases of PC with transgrediens involvement of the dorsal feet. OBJECTIVES: To document the extension of their disease to the dorsum of the feet in patients with mutation-confirmed PC, to report the natural history of PC with such transgrediens involvement, to generate hypotheses regarding aetiology, and to suggest prevention and treatment modalities. METHODS: Genetically confirmed cases of PC with transgrediens foot involvement were verified through the International Pachyonychia Congenita Research Registry (IPCRR) and characterized via telephone survey and photography. RESULTS: Seven patients with PC in the IPCRR were confirmed to have transgrediens lesions on the dorsal feet (six KRT6A mutations; one KRT16 mutation). Six cases had pre-existing nontransgrediens keratoderma and all cases reported standing, wearing shoes, foot moisture, and/or infection as exacerbating or predisposing factors. Improvement, reported in six cases, was attributed to use of antibiotics or gentian violet, or improved footwear. CONCLUSIONS: Transgrediens involvement of the dorsal feet is a rare manifestation of mutation-confirmed PC and may be more common in patients who carry a KRT6A mutation. Trauma, friction, infection and wound healing may exacerbate or predispose toward transgrediens lesions. It remains to be proven whether transgrediens-associated infection is causal or represents a primary or secondary process. Patients with PC who develop transgrediens lesions may benefit from fungal and bacterial cultures, followed by appropriate antimicrobial treatments. Efforts to decrease skin friction and moisture may also improve and/or prevent transgrediens spread.


Assuntos
Dermatoses do Pé/diagnóstico , Paquioníquia Congênita/diagnóstico , Adolescente , Adulto , Idoso , Feminino , Dermatoses do Pé/genética , Heterozigoto , Humanos , Queratina-16/genética , Queratina-6/genética , Masculino , Pessoa de Meia-Idade , Mutação/genética , Paquioníquia Congênita/genética
9.
G Ital Dermatol Venereol ; 145(5): 597-602, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20930694

RESUMO

Malignant melanoma is one of the most lethal cancers whose treatment options are limited once it has metastasized. Recent advances in molecular technology have improved our understanding of the underlying mechanisms of melanoma pathogenesis. In this article, we highlight several pathways that have been implicated in melanoma-genesis. While a cure is not yet within grasp, the picture on the horizon is less hazy and the next decade promises to yield exciting new therapeutic discoveries.


Assuntos
Melanoma/tratamento farmacológico , Melanoma/genética , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/genética , Humanos , Melanoma/patologia , Invasividade Neoplásica , Neoplasias Cutâneas/patologia
10.
Curr Mol Med ; 9(8): 929-34, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19925405

RESUMO

Angiogenesis is a major factor in the development of benign, inflammatory, and malignant processes of the skin. Endothelial cells are the effector cells of angiogenesis, and understanding their response to growth factors and inhibitors is critical to understanding the pathogenesis and treatment of skin disease. Hemangiomas, benign tumors of endothelial cells, represent the most common tumor of childhood. In our previous studies, we have found that tumor vasculature in human solid tumors expresses similarities in signaling to that of hemangiomas, making the knowledge of signaling in hemangiomas widely applicable. These similarities include expression of reactive oxygen, NFkB and akt in tumor vasculature. Furthermore, we have studied malignant vascular tumors, including hemangioendothelioma and angiosarcoma and have shown distinct signaling abnormalities in these tumors. The incidence of these tumors is expected to rise due to environmental insults, such as radiation and lumpectomy for breast cancer, dietary and industrial carcinogens (hepatic angiosarcoma), and chronic ultraviolet exposure and potential Agent Orange exposure. I hypothesize that hemangiomas, angiosarcomas, and vascular malformations represent the extremes of signaling abnormalities seen in pathogenic angiogenesis.


Assuntos
Hemangioma/irrigação sanguínea , Hemangiossarcoma/irrigação sanguínea , Neovascularização Patológica/patologia , Transdução de Sinais , Malformações Vasculares/fisiopatologia , Animais , Humanos
11.
Curr Pharm Des ; 11(3): 357-73, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15723631

RESUMO

Cancer is a general term used to describe many disease states, each of which are characterized by abnormal cell proliferation. The causes which bring about this abnormal cellular behavior are specific to each type of cancer. The success of tumor-targeted therapy is limited by this diversity. One common denominator for all types of cancer is the requirement of a suitable blood supply. Therefore, tumor vasculature has emerged as a potential target for therapeutic intervention. New blood vessel growth from preexisting vasculature stimulated by biochemical signals is termed angiogenesis. Tumor masses require a constant supply of oxygen and nutrients, and a means of efficient waste removal to ensure sustained development. Diffusion from nearby capillaries can supply adequate nutrition for tumors less than 2 mm in size, but for continued growth the tumors must develop their own blood supply. Alteration of the delicate balance of angiogenic stimulating factors and angiogenic inhibitors results in the phenotypic change from quiescence to active endothelial proliferation. To date, this angiogenic switch is not completely understood. The goal of antiangiogenic therapy is to interfere with these mechanisms and prevent tumor cells from developing a viable blood supply. Fumagillin is a naturally occurring antifungal agent. Curcumin is a natural product isolated from the spice turmeric. Both compounds have been shown to have antiangiogenic properties in vitro and in vivo. This paper describes efforts to design and prepare fumagillin and curcumin analogs and evaluate their corresponding antiangiogenic activities.


Assuntos
Inibidores da Angiogênese/síntese química , Curcumina/análogos & derivados , Curcumina/síntese química , Ácidos Graxos Insaturados/síntese química , Inibidores da Angiogênese/uso terapêutico , Animais , Cicloexanos , Avaliação Pré-Clínica de Medicamentos/métodos , Humanos , Sesquiterpenos , Tecnologia Farmacêutica/métodos , Tecnologia Farmacêutica/tendências
12.
Mod Pathol ; 14(12): 1195-9, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11743040

RESUMO

Angiogenesis has been implicated in the progression of human neoplasia from benign precursor to invasive and metastatic phenotypes. The acquisition of dominant oncogenes in preneoplastic cells in vitro and in vivo has been associated with the increased ability of tumor cells to secrete angiogenic mediators and recruit blood vessels. However, in a subset of benign lesions, high levels of angiogenesis have been found before the conversion to invasive and metastatic phenotypes. In many of these benign lesions, dominant oncogenic pathways are activated first; then as malignant potential is acquired, there is a loss of nuclear tumor suppressor genes, such as p53 and p16. We studied neuroendocrine lung tumors (NLT) ranging from typical and atypical carcinoid tumors to large cell neuroendocrine and small cell carcinomas in order to determine whether angiogenesis (as assessed by mean vessel density) and proliferation rates (as assessed by MIB-1 nuclear immunohistochemical staining) correlate with tumor type. We found that increased rates of proliferation, but not angiogenesis, correlate with tumor type. The association of increased proliferation and tumor type may prove to be clinically useful and shed light on the role of sequential oncogenic alterations in NLT.


Assuntos
Tumor Carcinoide/patologia , Carcinoma de Células Pequenas/patologia , Neoplasias Pulmonares/patologia , Neovascularização Patológica/patologia , Antígenos Nucleares , Tumor Carcinoide/irrigação sanguínea , Tumor Carcinoide/química , Carcinoma de Células Grandes/irrigação sanguínea , Carcinoma de Células Grandes/química , Carcinoma de Células Grandes/patologia , Carcinoma de Células Pequenas/irrigação sanguínea , Carcinoma de Células Pequenas/química , Contagem de Células , Divisão Celular , Humanos , Imuno-Histoquímica , Antígeno Ki-67 , Neoplasias Pulmonares/irrigação sanguínea , Neoplasias Pulmonares/química , Índice Mitótico , Proteínas Nucleares/análise , Molécula-1 de Adesão Celular Endotelial a Plaquetas/análise
13.
J Am Acad Dermatol ; 45(5): 707-11, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11606920

RESUMO

BACKGROUND: Keloids are a common lesion arising from sites of previous trauma and are a considerable source of morbidity because of continued growth of lesions, pruritus, and physical appearance. They consist of mesenchymal cells embedded in a stroma of disordered collagen matrix. Clinically, keloids are distinguished from scars in that keloids demonstrate continued growth over the borders of the original injury. Keloids appear with increased frequency in patients of African and Asian descent. Currently, no entirely satisfactory method of treatment exists for these lesions. Recently, a patient who was enrolled in a clinical trial of topical tacrolimus for atopic dermatitis applied this drug to a keloid and noted clearing. OBJECTIVE: Based on this clinical observation and the observation that rapamycin, a chemically similar compound to tacrolimus, is known to inhibit signaling from the gli-1 oncogene, we examined keloids and scars for expression of Gli-1 protein. METHODS: Skin sections from keloids and scars were examined by immunohistochemical staining for gli-1. To further confirm the presence of gli-1 expression in keloids, reverse transcriptase-polymerase chain reaction was carried out. RESULTS: Expression of gli-1 was strongly elevated in keloids compared with scars. CONCLUSION: These results provide a rationale for the treatment of keloids with topical rapamycin analogs, including tacrolimus. Clinical trials of topical tacrolimus are warranted.


Assuntos
Regulação da Expressão Gênica , Queloide/imunologia , Proteínas Oncogênicas/biossíntese , Fatores de Transcrição/biossíntese , DNA/análise , Humanos , Imuno-Histoquímica , Queloide/patologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transativadores , Proteína GLI1 em Dedos de Zinco
14.
J Am Acad Dermatol ; 45(3): 414-9, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11511840

RESUMO

BACKGROUND: Melanoma is the most lethal form of skin cancer. Diagnosis of amelanotic melanoma and detection of micrometastases in sentinel lymph nodes pose diagnostic and therapeutic dilemmas for the dermatopathologist and clinician. OBJECTIVE: The purpose of this article is to determine the utility of immunohistochemistry using antibodies specific for microphthalmia in the identification of melanocytic lesions in the skin, eye, central nervous system, and sentinel lymph nodes. METHODS: Paraffin-embedded, formalin-fixed specimens of cutaneous melanoma, including amelanotic melanoma and lentigo maligna melanoma, were stained with antibodies specific for microphthalmia. In addition, paraffin sections of extracutaneous lesions, including sentinel lymph nodes, uveal melanoma, and central nervous system melanocytomas, were stained with the specific microphthalmia antibody. RESULTS: All cutaneous melanomas stained positively with microphthalmia, as did uveal melanomas and central nervous system melanocytomas. These findings confirm the melanocytic origin of melanocytomas and uveal melanomas and demonstrate that microphthalmia staining can be used to establish melanocytic origin of neoplasms. In addition, micrometastases were easily detected in sentinel lymph nodes. CONCLUSION: Microphthalmia transcription factor immunohistochemistry is a valuable tool in the identification of melanocytic lesions in numerous sites. Use of this stain may facilitate detection of micrometastases in sentinel lymph nodes.


Assuntos
Anticorpos Antineoplásicos , Biomarcadores Tumorais/imunologia , Proteínas de Ligação a DNA/imunologia , Melanoma/diagnóstico , Neoplasias Cutâneas/diagnóstico , Fatores de Transcrição , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/secundário , Neoplasias Oculares/diagnóstico , Neoplasias Oculares/secundário , Humanos , Imuno-Histoquímica/normas , Metástase Linfática , Melanoma/secundário , Fator de Transcrição Associado à Microftalmia , Inclusão em Parafina , Sensibilidade e Especificidade , Neoplasias Cutâneas/patologia
15.
J Am Acad Dermatol ; 45(3): 462-5, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11511849

RESUMO

Dermal angiomatosis of the breast is an extremely rare disorder of unknown origin characterized by increased angiomatosis and ulceration. We report a case of a young woman whose disorder responded to isotretinoin. Our findings have potential relevance to the treatment of skin disorders in which ulceration is a prominent feature.


Assuntos
Angiomatose/diagnóstico , Dermatopatias/diagnóstico , Adulto , Angiomatose/tratamento farmacológico , Angiomatose/patologia , Mama , Fármacos Dermatológicos/uso terapêutico , Diagnóstico Diferencial , Feminino , Humanos , Isotretinoína/uso terapêutico , Dermatopatias/tratamento farmacológico , Dermatopatias/patologia
16.
Am J Pathol ; 159(2): 483-91, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11485907

RESUMO

Angiomyolipomas are benign tumors of the kidney derived from putative perivascular epithelioid cells, that may undergo differentiation into cells with features of melanocytes, smooth muscle, and fat. To gain further insight into angiomyolipomas, we have generated the first human angiomyolipoma cell line by sequential introduction of SV40 large T antigen and human telomerase into human angiomyolipoma cells. These cells show phenotypic characteristics of angiomyolipomas, namely differentiation markers of smooth muscle (smooth muscle actin), adipose tissue (peroxisome proliferator-activator receptor gamma, PPARgamma), and melanocytes (microophthalmia, MITF), thus demonstrating that a single cell type can exhibit all of these phenotypes. These cells should serve as a valuable tool to elucidate signal transduction pathways underlying renal angiomyolipomas.


Assuntos
Angiomiolipoma/patologia , Neoplasias Renais/patologia , Telomerase/metabolismo , Actinas/análise , Tecido Adiposo/citologia , Tecido Adiposo/patologia , Angiomiolipoma/genética , Angiomiolipoma/ultraestrutura , Antígenos Transformantes de Poliomavirus/genética , Técnicas de Cultura de Células/métodos , Humanos , Imuno-Histoquímica , Neoplasias Renais/genética , Neoplasias Renais/ultraestrutura , Melanócitos/citologia , Melanócitos/patologia , Proteínas Quinases Ativadas por Mitógeno/análise , Músculo Liso/citologia , Músculo Liso/patologia , Fenótipo , Fosforilação , Proteínas/análise , Proteínas/genética , Receptores Citoplasmáticos e Nucleares/análise , Receptores Citoplasmáticos e Nucleares/metabolismo , Proteínas Repressoras/análise , Proteínas Repressoras/genética , Vírus 40 dos Símios/genética , Telomerase/análise , Fatores de Transcrição/análise , Fatores de Transcrição/metabolismo , Transfecção , Proteína 1 do Complexo Esclerose Tuberosa , Proteína 2 do Complexo Esclerose Tuberosa , Células Tumorais Cultivadas , Proteínas Supressoras de Tumor
17.
J Am Acad Dermatol ; 44(2): 193-7, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11174372

RESUMO

BACKGROUND: Tumors of endothelium range from benign hemangiomas of infancy to highly malignant angiosarcomas of the elderly. Hemangiomas are the most common tumors in infants and may affect up to 10% of all children. The biologic behavior of these lesions ranges from self-resolving, in the case of hemangiomas and pyogenic granulomas, to lethal metastatic neoplasms in the case of angiosarcoma. Although the clinical outcomes of these diseases are easily distinguished, the biologic basis for these differences is not well understood. Activation of mitogen-activated protein kinase (MAPK) is an important signal transduction mechanism that may predict response of a tumor to chemotherapy. OBJECTIVE: Our purpose was to examine expression of phosphorylated (activated) MAPK in hemangiomas of infancy, pyogenic granulomas, hemangioendotheliomas, and angiosarcomas to determine whether phosphorylated MAPK was expressed in endothelial tumors. In addition, we examined endothelial tumors of infectious origin, Kaposi's sarcoma, and verruga peruana. METHODS: Skin sections from benign and malignant endothelial tumors, including hemangioma of infancy, angiosarcoma, and infectious endothelial lesions (Kaposi's sarcoma, verruga peruana) were stained with an antibody specific for phosphorylated MAPK. RESULTS: We demonstrated strong expression of phosphorylated MAPK in benign endothelial tumors, including capillary hemangioma of infancy and pyogenic granuloma, and greatly decreased expression in angiosarcoma. In addition, infectious endothelial tumors stained strongly with this antibody, similar to benign tumors. The presence of immunoreactive phosphorylated MAPK appears to be inversely correlated with degree of malignancy. CONCLUSION: We demonstrate that the use of antibodies specific for signal transduction pathways is feasible in paraffin-fixed tissue. Thus the activity of a given signal transduction pathway can be ascertained in a biopsy specimen. Immunohistochemistry for phosphorylated MAPK may help the pathologist distinguish benign from malignant endothelial processes and thus guide therapy.


Assuntos
Proteínas Quinases Ativadas por Mitógeno/análise , Neoplasias de Tecido Vascular/enzimologia , Neoplasias Cutâneas/enzimologia , Granuloma Piogênico/tratamento farmacológico , Granuloma Piogênico/enzimologia , Granuloma Piogênico/patologia , Hemangioendotelioma/tratamento farmacológico , Hemangioendotelioma/enzimologia , Hemangioendotelioma/patologia , Hemangioma/tratamento farmacológico , Hemangioma/enzimologia , Hemangioma/patologia , Hemangiossarcoma/tratamento farmacológico , Hemangiossarcoma/enzimologia , Hemangiossarcoma/patologia , Humanos , Imuno-Histoquímica , Neoplasias de Tecido Vascular/tratamento farmacológico , Neoplasias de Tecido Vascular/patologia , Sarcoma de Kaposi/tratamento farmacológico , Sarcoma de Kaposi/enzimologia , Sarcoma de Kaposi/patologia , Dermatopatias/tratamento farmacológico , Dermatopatias/enzimologia , Dermatopatias/patologia , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia , Verrugas/tratamento farmacológico , Verrugas/enzimologia , Verrugas/patologia
18.
Am J Pathol ; 157(6): 1937-45, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11106566

RESUMO

Activated ras causes increased activity of several signal transduction systems, including the mitogen-activated protein kinase kinase (MAPKK) pathway and the phosphoinositol-3-kinase (PI-3-K) pathway. We have previously shown that the PI-3-K pathway plays a major role in regulation of ras-mediated tumor angiogenesis in angiosarcoma cells. However, the contribution of the MAPKK pathway to tumorigenesis and angiogenesis is not fully understood. Overexpression of constitutively active forms of MAPKK has previously been shown to transform nonmalignant NIH3T3 fibroblasts, but the effect of down-regulation of MAPKK on tumorigenesis and angiogenesis in a well established tumor has not been fully explored. We introduced a dominant negative MAPKK gene into SVR murine angiosarcoma cells. Introduction of a dominant negative MAPKK causes a significant decrease in proliferation rate in vitro and morphological reversion. Cells expressing the dominant negative MAPKK have a greatly decreased ability to form colonies in soft agar compared with wild-type cells. Despite the decreased cell growth in vitro and inability to grow in soft agar, the cells were equally tumorigenic in nude mice. Our results suggest that the MAPKK pathway is required for soft agar growth of angiosarcoma cells, and separates the phenotypes of soft agar growth versus in vivo tumorigenicity. These findings have implications in the development of signal transduction modulators as potential antineoplastic agents.


Assuntos
Hemangiossarcoma/etiologia , Hemangiossarcoma/patologia , Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores , Ágar , Animais , Ciclo Celular , Divisão Celular , Cromonas/farmacologia , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Flavonoides/farmacologia , Expressão Gênica , Genes Dominantes , Camundongos , Camundongos Nus , Quinases de Proteína Quinase Ativadas por Mitógeno/genética , Morfolinas/farmacologia , Fenótipo , Transdução de Sinais/efeitos dos fármacos , Inibidores Teciduais de Metaloproteinases/metabolismo , Células Tumorais Cultivadas
19.
Arthritis Rheum ; 43(10): 2189-201, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11037878

RESUMO

OBJECTIVE: To develop a reproducible immortalized human chondrocyte culture model for studying the regulation of chondrocyte functions relevant to arthritic diseases in adult humans. METHODS: Primary adult articular chondrocytes were immortalized with a retrovirus expressing a temperature-sensitive mutant of SV40-large T antigen (tsTAg). The established tsT/AC62 chondrocyte cell line was examined in monolayer and alginate culture systems. The levels of messenger RNA (mRNA) encoding cartilage matrix proteins and interleukin-1beta (IL-1beta)-inducible mRNA were analyzed by reverse transcriptase-polymerase chain reaction. Matrix protein synthesis was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of 35S-sulfate-labeled proteoglycans and Western blotting of type II collagen and aggrecan. Type II collagen (COL2A1)-luciferase reporter gene expression was analyzed by transient transfection. Phosphorylated stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), p38 mitogen-activated protein kinase (p38 MAPK), and activating transcription factor 2 (ATF-2) were detected by Western blotting. RESULTS: The tsT/AC62 cells expressed TAg at the permissive temperature (32degrees C), and the loss of TAg at 37 degrees C and 39 degrees C correlated with decreased cell proliferation. Cells in alginate culture deposited abundant alcian blue-stainable matrix and continued to proliferate at 32 degrees C. Preferential retention of aggrecan was observed in the cell-associated matrix, while biglycan and decorin were secreted into the medium of monolayer and alginate cultures. The levels of COL2A1 and aggrecan mRNA were increased after transfer from monolayer to alginate culture at 32 degrees C. Treatment with IL-1beta decreased COL2A1 and aggrecan mRNA levels and increased the levels of matrix metalloproteinases 1, 3, and 13 mRNA, as well as those of cyclooxygenase 2, type I collagen, and secretory phospholipase A2 type IIA mRNA, but not those of inducible nitric oxide synthase mRNA. IL-1beta also stimulated phosphorylation of p38 MAPK, SAPK/JNK, and ATF-2. The p38 MAPK-selective inhibitor, SB203580, partially reversed IL-1beta-induced inhibition of COL2A1 mRNA levels and COL2A1-luciferase reporter gene expression. CONCLUSION: The tsT/AC62 cells provide a reproducible model that mimics the adult articular chondrocyte phenotype, particularly in alginate culture, and demonstrates characteristic responses to IL-1beta. These studies also show, for the first time, that p38 MAPK is one of the signals required for IL-1beta-induced inhibition of COL2A1 gene expression. Availability of this model will permit identification of signals that regulate cytokine responses, and will also provide rational strategies for targeting these pathways.


Assuntos
Condrócitos/metabolismo , Adulto , Azul Alciano , Alginatos/farmacologia , Antígenos Transformantes de Poliomavirus/biossíntese , Células Cultivadas , Corantes , Proteínas da Matriz Extracelular/genética , Humanos , Interleucina-1/genética , Masculino , Metaloproteinase 1 da Matriz/análise , Metaloproteinase 3 da Matriz/análise , Pessoa de Meia-Idade , Fenótipo , Proteoglicanas/biossíntese , RNA Mensageiro/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...